Live Breaking News & Updates on Biotechnologies corporation

Stay informed with the latest breaking news from Biotechnologies corporation on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Biotechnologies corporation and stay connected to the pulse of your community

Peregrine Capital Management LLC Has $1.84 Million Holdings in Adaptive Biotechnologies Co. (NASDAQ:ADPT)

Peregrine Capital Management LLC lessened its holdings in shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT – Free Report) by 14.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 375,638 shares of the company’s stock after selling 64,317 shares during the […]

Chad , Julie-rubinstein , Adaptive-biotechnologies-corporation , Financial-services-group-inc , Meeder-asset-management-inc , Healthcare-of-ontario-pension-plan-trust-fund , Goldman-sachs-group , Metlife-investment-management , Nasdaq , Jpmorgan-chase-co , Adaptive-biotechnologies-co , Peregrine-capital-management

Adaptive Biotechnologies Co. (NASDAQ:ADPT) Holdings Lowered by Peregrine Capital Management LLC

Peregrine Capital Management LLC reduced its holdings in Adaptive Biotechnologies Co. (NASDAQ:ADPT – Free Report) by 14.6% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 375,638 shares of the company’s stock after selling 64,317 shares during the quarter. Peregrine Capital Management LLC […]

Chad , Stacyl-taylor , Adaptive-biotechnologies-corporation , Financial-services-group-inc , Healthcare-of-ontario-pension-plan-trust-fund , Metlife-investment-management , Jpmorgan-chase-co , Exchange-commission , Adaptive-biotechnologies-co , Meeder-asset-management-inc , Goldman-sachs-group

Analysts Set Adaptive Biotechnologies Co. (NASDAQ:ADPT) Target Price at $7.25

Shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT – Get Free Report) have received an average recommendation of “Moderate Buy” from the six research firms that are covering the stock, Marketbeat.com reports. Two analysts have rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average 12-month target price […]

Kyle-piskel , Stacyl-taylor , Meeder-asset-management-inc , Nasdaq , Goldman-sachs-group , Adaptive-biotechnologies-co , Financial-services-group-inc , Adaptive-biotechnologies-corporation , Jpmorgan-chase-co , Adaptive-biotechnologies , Get-free-report , Biotechnologies-trading-down

Adaptive Biotechnologies (NASDAQ:ADPT) & Ikena Oncology (NASDAQ:IKNA) Head to Head Comparison

Adaptive Biotechnologies (NASDAQ:ADPT – Get Free Report) and Ikena Oncology (NASDAQ:IKNA – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, earnings, institutional ownership, risk, profitability and valuation. Volatility & Risk Adaptive Biotechnologies has a […]

Boston , Massachusetts , United-states , Seattle , Washington , Genentech-inc , Ikena-oncology-inc , Microsoft-corporation , Adaptive-biotechnologies-corporation , Adaptive-biotechnologies , Get-free-report

Adaptive Biotechnologies Names Kyle Piskel New CFO

Adaptive Biotechnologies Corp (ADPT) has issued an update. Adaptive Biotechnologies Corporation has appointed Kyle Piskel as its new Chief Financia...

Kyle-piskel , Adaptive-biotechnologies-corporation , Adaptive-biotechnologies-corp , Biotechnologies-corporation , Chief-financia , News , Ggregator , Reaking-news , Uration , Edia ,

BTIG Research Cuts Adaptive Biotechnologies (NASDAQ:ADPT) Price Target to $5.00

Adaptive Biotechnologies (NASDAQ:ADPT – Free Report) had its price objective decreased by BTIG Research from $6.00 to $5.00 in a research report sent to investors on Thursday morning, Benzinga reports. BTIG Research currently has a buy rating on the stock. Several other equities research analysts have also recently weighed in on ADPT. JPMorgan Chase & […]

Chad , Jpmorgan-chase-co , Adaptive-biotechnologies-company-profile , Financial-services-group-inc , Group-plc , Vident-investment-advisory , Nasdaq , Adaptive-biotechnologies-corporation , Commonwealth-equity-services , Goldman-sachs-group , Adaptive-biotechnologies

Adaptive Biotechnologies Co. (NASDAQ:ADPT) Given Average Rating of "Moderate Buy" by Analysts

Adaptive Biotechnologies Co. (NASDAQ:ADPT – Get Free Report) has received an average rating of “Moderate Buy” from the five brokerages that are presently covering the stock, MarketBeat Ratings reports. Two research analysts have rated the stock with a hold rating and three have given a buy rating to the company. The average 1-year price objective […]

Chad , United-states , American , Adaptive-biotechnologies-co , Investment-management , Adaptive-biotechnologies-corporation , Jpmorgan-chase-co , Nasdaq , Securities-exchange-commission , Hermes-inc , American-century-companies-inc

Adaptive Biotechnologies Co. (NASDAQ:ADPT) Receives Average Rating of "Moderate Buy" from Brokerages

Adaptive Biotechnologies Co. (NASDAQ:ADPT – Get Free Report) has been given a consensus rating of “Moderate Buy” by the five analysts that are currently covering the stock, Marketbeat Ratings reports. Two research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The average 1-year price […]

Chad , Meeder-asset-management-inc , Goldman-sachs-group , Nasdaq , Adaptive-biotechnologies-corporation , Jpmorgan-chase-co , Adaptive-biotechnologies-company-profile , Adaptive-biotechnologies-co , Financial-services-group-inc , Adaptive-biotechnologies , Get-free-report

Lewis Asset Management LLC Takes Position in Adaptive Biotechnologies Co. (NASDAQ:ADPT)

Lewis Asset Management LLC Takes Position in Adaptive Biotechnologies Co. (NASDAQ:ADPT)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Julie-rubinstein , Stacyl-taylor , Gilder-gagnon-howe-co , Bellevue-group , Blackrock-inc , Norges-bank , Nasdaq , Adaptive-biotechnologies-company-profile , Investment-management , Jpmorgan-chase-co , Adaptive-biotechnologies-corporation , Lewis-asset-management

Lewis Asset Management LLC Makes New $96,000 Investment in Adaptive Biotechnologies Co. (NASDAQ:ADPT)

Lewis Asset Management LLC Makes New $96,000 Investment in Adaptive Biotechnologies Co. (NASDAQ:ADPT)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Montreal , Quebec , Canada , Julie-rubinstein , Kyle-piskel , Exchange-commission , Financial-services-group-inc , Nasdaq , Citigroup-inc , Adaptive-biotechnologies-company-profile , Adaptive-biotechnologies-corporation , Jpmorgan-chase-co